×
About 6,685 results

ALLMedicine™ Basal Cell Carcinoma Center

Research & Reviews  2,234 results

A review of the evidence for Mohs micrographic surgery in the treatment of basal cell c...
https://doi.org/10.1111/ced.15266
Clinical and Experimental Dermatology; Brown AC, Brindley L et. al.

May 22nd, 2022 - MMS is considered the gold standard treatment for basal cell carcinoma (BCC) particularly for sites with a high-risk of incomplete excision such as the central face, tumours with an aggressive growth pattern and consequent unpredictable sub-clinic...

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
https://clinicaltrials.gov/ct2/show/NCT00001163

May 20th, 2022 - Background: Persons may be prone to develop cancer for a variety of reasons including: inherited predisposition benign, premalignant, or malignant conditions; environmental exposures shared by family members; previous tumors, immune deficiency, or...

Unusual Basal Cell Carcinoma in an Adult Woman With Gorlin-Goltz Syndrome.
https://doi.org/10.1001/jamaophthalmol.2022.0637
JAMA Ophthalmology; Loveridge-Easther C, Weatherhead R

May 20th, 2022 - Unusual Basal Cell Carcinoma in an Adult Woman With Gorlin-Goltz Syndrome.|2022|Loveridge-Easther C,Weatherhead R,|diagnosis,pathology,diagnostic imaging,surgery,diagnosis,surgery,

Clear Cell Renal Cell Carcinoma with Immunotherapy Effect Mimicking Xanthogranulomatous...
https://doi.org/10.1177/10668969221101873
International Journal of Surgical Pathology; Wang Y, Ganesan S et. al.

May 17th, 2022 - Renal cell carcinoma is now increasingly treated with checkpoint inhibitor therapy, predominantly in the metastatic setting or occasionally in the adjuvant setting; however, there is little published histopathology data demonstrating the post-ther...

Advanced basal cell carcinoma: What dermatologists need to know about diagnosis.
https://doi.org/10.1016/j.jaad.2022.03.023
Journal of the American Academy of Dermatology; Krakowski AC, Hafeez F et. al.

May 17th, 2022 - Basal cell carcinoma (BCC) is the most common human cancer, with approximately 3.6 million cases diagnosed each year. About 2000 deaths annually in the United States are attributed to basal and squamous cell skin cancers. There is a direct link be...

see more →

Guidelines  7 results

Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of t...
https://doi.org/10.1016/j.prro.2019.10.014
Practical Radiation Oncology; Likhacheva A, Awan M et. al.

Dec 14th, 2019 - This guideline reviews the evidence for the use of definitive and postoperative radiation therapy (RT) in patients with basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). The American Society for Radiation Oncology convened a...

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdiscipli...
https://doi.org/10.1016/j.ejca.2019.06.003
European Journal of Cancer (Oxford, England : 1990); Peris K, Fargnoli MC et. al.

Jul 10th, 2019 - Basal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization of Research and Treatmen...

Guidelines of care for the management of basal cell carcinoma.
https://doi.org/10.1016/j.jaad.2017.10.006
Journal of the American Academy of Dermatology; , et. al.

Jan 15th, 2018 - Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly cura...

Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873942
The Journal of Laryngology and Otology; Newlands C, Currie R et. al.

Nov 15th, 2016 - This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. This paper provides consensus recommendations on the management of cutaneous basal cell carcinoma and squamous c...

Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2016.0065
Journal of the National Comprehensive Cancer Network : JN... Bichakjian CK, Olencki T et. al.

May 11th, 2016 - Basal cell carcinoma (BCC) of the skin is the most common cancer, with a higher incidence than all other malignancies combined. Although it is rare to metastasize, patients with multiple or frequently recurring BCC can suffer substantial comorbidi...

see more →

Drugs  16 results see all →

Clinicaltrials.gov  76 results

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
https://clinicaltrials.gov/ct2/show/NCT00001163

May 20th, 2022 - Background: Persons may be prone to develop cancer for a variety of reasons including: inherited predisposition benign, premalignant, or malignant conditions; environmental exposures shared by family members; previous tumors, immune deficiency, or...

The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)
https://clinicaltrials.gov/ct2/show/NCT05238363

May 5th, 2022 - Following basal cell carcinoma, Cutaneous Squamous Cell Carcinoma (CSCC) is the most common skin cancer and its incidence remains on a steady rise. The vast majority of CSCC lesions are treated with surgical resection and have a cure rate exceedin...

CemiplimAb Survivorship Epidemiology
https://clinicaltrials.gov/ct2/show/NCT03836105

Apr 26th, 2022 - The objectives of the study are: To describe the effectiveness of cemiplimab 350 mg administered every 3 weeks (Q3W) for treatment of patients with advanced cutaneous squamous cell carcinoma (CSCC) and patients with advanced basal cell carcinoma (...

Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N
https://clinicaltrials.gov/ct2/show/NCT04323202

Apr 12th, 2022 - This is a phase 1 study looking at anti-PD-1 Neoadjuvant therapy in Basal cell carcinoma in participants with locoregionally advanced, but resectable basal cell carcinoma of the head and neck. Participants will undergo fine cut CT imaging (head an...

New Imaging Procedures and Therapeutic Approach in Basal Cell Carcinoma Management
https://clinicaltrials.gov/ct2/show/NCT05324202

Apr 12th, 2022 - The aim of this study is to show that the Nd:YAG laser could be a promising alternative treatment option in the management of low-risk basal cell carcinomas with similar high efficacy rates to surgery, and low recurrence rates evaluated over a tim...

see more →

News  331 results

Q&A with Hubert (Hugh) Greenway, MD
https://www.mdedge.com/dermatology/article/254376/dermatologic-surgery/qa-hubert-hugh-greenway-md
Doug Brunk

May 5th, 2022 - Anyone who practices Mohs micrographic surgery is likely to know the name Hugh Greenway, MD, the longtime head of Mohs and dermatologic surgery at Scripps Clinic in San Diego, who was also recently selected as program director for cutaneous oncolo.

Necrosis of the Ear Following Skin Cancer Resection
https://www.mdedge.com/dermatology/article/254111/nonmelanoma-skin-cancer/necrosis-ear-following-skin-cancer-resection
Alecia M. Blaszczak, PhD, Nadia Abidi, MD et. al.

Apr 26th, 2022 - Mohs micrographic surgery (MMS) frequently is used in surgical removal of cancerous cutaneous lesions on cosmetically sensitive areas and anatomically challenging sites, including the ears. The vascular supply of the ear is complex and includes se.

2021 Approvals Expand Access to Care for Patients Across Tumor Types
https://www.onclive.com/view/2021-approvals-expand-access-to-care-for-patients-across-tumor-types

Mar 10th, 2022 - Last year marked the 50th anniversary of the National Cancer Act of 1971, a landmark legislation that committed to funding biomedical research, establishing oncology training programs, and building a nationwide network of cancer treatment centers....

Fast Five Quiz: Metastatic Melanoma
https://www.medscape.com/viewarticle/966638

Feb 23rd, 2022 - Malignant melanoma is the third most common cutaneous cancer after basal cell carcinoma and squamous cell carcinoma. Although most malignant melanomas are diagnosed at an early stage, this cancer also has the inherent ability to spread aggressivel...

Fungating Mass on the Abdominal Wall
https://www.mdedge.com/dermatology/article/251767/nonmelanoma-skin-cancer/fungating-mass-abdominal-wall
Blake Everett Vest, MD, Johnson Wong, MD et. al.

Feb 14th, 2022 - The Diagnosis: Basal Cell Carcinoma Histopathology was consistent with fungating basal cell carcinoma (BCC). The nodules were comprised of syncytial basaloid cells with high nuclear to cytoplasmic ratios, numerous mitotic figures, fibromyxoid stro.

see more →

Patient Education  10 results see all →